Prenuvo Review

Prenuvo is one of the two major direct-to-consumer whole-body MRI companies. Ezra is the other. A single session of roughly 60 minutes images head, neck, spine, chest, abdomen and pelvis, and a board-certified radiologist produces a written report. Pricing runs from about $999 for a torso-focused scan to about $2,499 for the full head-to-pelvis protocol, depending on scope and location.

The product is a one-time purchase, not a program. There is no membership, no blood panel, no prescription and no clinician who follows you afterwards. That framing matters more than any feature comparison, because the value of the scan depends almost entirely on what you do with the report — and the report lands in your inbox, not in a physician's queue. This review covers what is inside the scan, what the price does and does not include, what the visit is actually like, and the specific cases where a different screening tool is the better purchase.

Public litigation

Prenuvo faces an open medical malpractice / negligence suit in New York (filed September 2024) alleging a radiologist missed stroke-related findings on a whole-body MRI. These are allegations, not findings — Washington Post.

Scorecard

What you get for the money

Prenuvo sells scanner time and a radiologist read, and the tier you buy determines how much anatomy is covered in that time. Everything downstream of the report is outside the purchase.

• Whole-body MRI, ~60 minutes. Bundled at the full-body tier. Head, neck, cervical, thoracic and lumbar spine, chest, abdomen and pelvis in a single continuous session.
• Torso-focused option. The entry tier from around $999 trades head and full-spine coverage for a lower price and less time in the bore.
• No contrast, no radiation, no needle. Bundled by design. The standard protocol requires no injected dye and no ionizing radiation.
• Board-certified radiologist review. Bundled. A named human radiologist signs the read.
• Structured written report. Bundled. Findings are grouped by anatomical region, each with a recommended action.
• Optional add-on protocols. An add-on, and only at some locations. Heart-specific sequences and expanded imaging are offered in certain markets; availability and pricing vary.
• Not included: any clinical care. No physician manages your findings, no prescriptions are written, and no follow-up imaging is ordered by Prenuvo. That work moves to your own doctor.
• Not included: bloodwork. Unlike a bundled program, nothing about your lipids, glucose, hormones or inflammation is measured here.

What it costs

The headline range is wide because it spans two different products. A torso-focused scan and a head-to-pelvis scan are not the same purchase, and the price gap between them is roughly the price of a second entry-level scan. Compare like for like when you shop this against Ezra's tiers.

None of this is insurance-covered on the front end. HSA and FSA eligibility depends on your plan administrator and on whether the scan is coded as elective screening, which it usually is. The line that turns a $1,500 decision into a $4,000 one is the workup: if the radiologist flags a lesion for confirmatory imaging, that second scan, the specialist visit and any biopsy are billed by the providers who perform them.

Signing up and the first visit

Booking is direct-to-consumer in most locations, with no physician referral required. You select a location and a scan tier online, then complete a medical-history form and an MRI safety screen. That safety screen is the gate that matters: implanted devices, retained metal, prior surgeries and claustrophobia are all assessed there, and any of them can end the process before you reach the scanner.

On the day, you change, remove all metal, and lie supine inside a closed bore for roughly an hour. There is no injection on the standard protocol. The scanner is loud and ear protection is provided. Movement degrades the images, so sequences occasionally have to be repeated, which extends the session. People who know they cannot lie still for an hour should say so at booking rather than discover it at minute fifteen.

Turnaround on the report is typically several days. What arrives is a region-by-region write-up: brain, neck, spine, chest, abdomen, pelvis, each with the findings and a recommended action — nothing further, re-image at a stated interval, or seek prompt evaluation. Expect the report to contain at least one item flagged for attention; that is normal for whole-body imaging and is not by itself a signal of disease. From booking to report in hand, the whole process usually runs one to three weeks depending on appointment availability in your metro.

What the scan covers

MRI images soft tissue well and images some things barely at all. Knowing which is which is the difference between a useful purchase and false reassurance. The full-body protocol typically covers:

• Brain. Masses, structural abnormalities and vascular findings including aneurysms.
• Neck. Thyroid nodules and other soft-tissue masses.
• Full spine. Cervical, thoracic and lumbar segments, including disc disease, degenerative change and bony lesions.
• Chest. Soft-tissue structures and the mediastinum. Lung parenchyma is not MRI's strength, which is a genuine gap for smokers and former smokers.
• Liver, gallbladder, pancreas, spleen. Lesions and cysts. Pancreatic coverage is one of the few places whole-body MRI reaches anatomy that no routine age-based screening test covers.
• Kidneys and adrenals. Masses and cysts — also the single most common source of benign incidental findings on these scans.
• Pelvis. Prostate in men; uterus and ovaries in women.
• Aorta and major vessels. Dimensions and aneurysmal dilation.

The gaps are as important as the coverage. This scan does not replace a colonoscopy, does not replace a mammogram, does not measure coronary calcium, and finds lung nodules less reliably than a low-dose CT. It also says nothing about blood-based cancer signals, which is why Galleri is layered alongside imaging rather than compared against it. Our full body MRI scan guide works through the coverage region by region, including where the modality is effectively blind and which eligibility rules rule people out before any of this matters.

Strengths

• Zero ionizing radiation. Repeating an MRI does not accumulate radiation dose the way repeated CT screening would.
• Genuine head-to-pelvis scope in one session. A single ~60-minute appointment covers brain, full spine and torso, which no other consumer screening product does in one sitting.
• Direct booking. No physician referral is required in most locations, which removes the gatekeeping step that blocks blood-based multi-cancer tests.
• A lower entry tier. The torso-focused option from around $999 is the cheapest way into whole-body-adjacent MRI screening among the providers compared here.
• Structured, actionable reporting. Findings arrive grouped by region with a stated recommended action rather than as raw radiology prose.
• Growing US footprint. Clinic coverage across major metros has expanded, shortening travel for a widening share of buyers.

Trade-offs

• Incidentaloma rate. Benign structural variants that require further imaging or biopsy to rule out are common. The cost, delay and anxiety of a workup that ends in nothing are real and unpriced.
• Clinical utility debated. Major medical societies do not currently recommend whole-body MRI screening for asymptomatic average-risk adults, and mortality benefit at population scale is unproven.
• Price and price spread. $999 to $2,499 is a wide band, and the cheaper end is a materially smaller scan. Not insurance-covered.
• No treatment relationship. The radiologist report is the end of the product. Nobody at Prenuvo manages what happens next.
• Coverage gaps against standard screening. Colon, breast, lung and coronary risk each require their own modality; a clean scan here does not clear them.
• Eligibility exclusions. Implanted devices, retained metal, bore-size and weight limits, and severe claustrophobia disqualify some buyers entirely.

How it compares

The table lists Prenuvo alongside its closest peers, listed alphabetically, with the same four criteria applied to every row. Ezra is the direct substitute — same modality, same one-time purchase, same endpoint at a radiologist report. Galleri is a complement rather than a rival, because a methylation-based blood test and an MRI look for entirely different signals. Fountain Life is the bundled route, where imaging is one line item inside a concierge membership.

Practically: between Prenuvo and Ezra, clinic proximity and protocol length usually decide it, since both end at the same kind of report. Between imaging and Galleri, the question is whether your concern is anatomy or cancer signal — Galleri reaches cancer types MRI cannot at roughly $949, and many buyers who can afford both do both. Between a scan and Fountain Life, the question is whether you want someone to act on the findings, which a $19,500-plus annual membership includes and a one-time scan does not.

Who should buy it — and who should not

Buy it if:

• You carry a documented cancer-predisposition syndrome. In Li-Fraumeni syndrome, whole-body MRI surveillance is already part of established clinical protocols rather than elective screening — a genuinely different calculus from the average buyer's.
• You have a family history of a cancer or structural condition that standard age-based screening does not cover, such as pancreatic cancer or aortic aneurysm.
• You have an unexplained persistent symptom and your physician wants broad soft-tissue imaging rather than a targeted study.
• You can absorb the follow-up workup out of pocket, because that cost is separate and not quoted at booking.

Look elsewhere if:

• Your real question is cancer risk rather than anatomy — buy Galleri instead, which screens 50+ cancer types from a blood draw at roughly $949.
• You want the imaging plus biomarkers plus a physician who owns the follow-up — buy a Fountain Life membership instead and budget the full year.
• You are overdue for a colonoscopy, mammogram or low-dose lung CT — buy those first, since they carry mortality-benefit evidence whole-body MRI does not.
• You want the shortest and cheapest possible time in an MRI bore — Ezra's ~30-minute Flash tier at roughly $1,395 is built for exactly that.

Retesting and what year two costs

Annual repeat scanning is commonly marketed and rarely justified for an average-risk adult with a clean baseline. Because MRI carries no radiation, the argument against repeating is not safety — it is yield. A second scan on an unchanged asymptomatic body finds less than the first did, while the probability of surfacing a fresh benign finding stays roughly flat. Repeating annually therefore raises your lifetime exposure to workups, not to radiation.

Year two is priced like year one: roughly $999 at the torso tier and up to roughly $2,499 for the full-body protocol, with no published returning-customer rate. A buyer committing to annual full-body scans is signing up for about $5,000 over two years before any downstream imaging.

A more defensible cadence for most average-risk adults is a baseline, then a repeat at two to three years, tightened only if the baseline flagged something to track. Where the baseline did flag a lesion, follow the interval stated in the report — it is anatomy-specific and usually shorter than a generic annual schedule. Where you carry a predisposition syndrome, the surveillance interval comes from your specialist, not from the scan provider.

Related

• Prenuvo cost breakdown
• Is Prenuvo worth it?
• Prenuvo vs Ezra — the two providers side by side
• Prenuvo alternatives — every real option compared
• Ezra review — the other whole-body MRI provider
• Galleri review — blood-based multi-cancer screening
• Fountain Life review — imaging bundled with biomarkers
• Doctor-led options — every physician-supervised program compared